Table 1 Characteristics of HAdV isolates in this study.
Isolate | Genotype (partial hexon) | Year of isolation | Patient’s age range | Patient’s sex | Specimen type | Clinical symptoms and outcome* | Genome size (bp) | Genotype classification (WGS) |
|---|---|---|---|---|---|---|---|---|
ADVJA-00-BE | HAdV2 | 2006 | 1–5 year | F | Upper respiratory tract | Meningitis suspected, but not confirmed; no hospitalization | 35,843 | HAdV2 |
ADVJA-05-BE | HAdV1 | 2014 | 1–5 year | M | Lower respiratory tract | Sudden infant death syndrome | 35,974 | HAdV1 |
ADVJA-13-BE | HAdV1 | 2002 | 1–5 year | F | Upper respiratory tract | Meningitis | 35,858 | HAdV1 |
ADVJA-23-BE | HAdV2 | 2005 | 1–5 year | M | Lower respiratory tract | Death | 35,813 | HAdV2 |
ADVJA-38-BE | HAdV2 | 2010 |  < 1 year | M | Upper respiratory tract | Fever, convulsions, hospitalization | 35,883 | HAdV2 |
ADVJA-41-BE | HAdV1 | 2014 | 1–5 year | M | Stool | Gastroenteritis | 35,859 | HAdV1 |
ADVJA-54-BE | HAdV2 | 2006 | 1–5 year | F | Stool | Abdominal pain, fever, gastroenteritis, no therapy | 35,826 | HAdV2 |
ADVJA-56-BE | HAdV2 | 2006 | 1–5 year | F | Stool | Gastroenteritis | 35,884 | HAdV2 |
ADVJA-60-BE | HAdV2 | 2000 |  < 1 year | M | Stool | Gastroenteritis, hospitalization | 35,839 | HAdV2 |
ADVJA-65-BE | HAdV5 | 2013 | 1–5 year | F | Stool | Oncological immunosuppressed, gastroenteritis | 35,881 | HAdV5 |
ADVJA-77-BE | HAdV2 | 2009 |  < 1 year | M | Upper respiratory tract | Cough, upper respiratory infection | 35,951 | HAdV2 |
ADVJA-78-BE | HAdV2 | 2006 | 1–5 year | M | lower respiratory tract | Sudden infant death syndrome | 35,890 | HAdV2 |
ADVJA-749-BE | HAdV2 | 2002 | 1–5 year | M | upper respiratory tract | Sepsis, meningitis, hospitalization | 35,853 | HAdV-C |
ADVJA-949-BE | HAdV5 | 2012 |  < 1 year | F | lower respiratory tract | Sudden infant death syndrome | 35,872 | HAdV5 |
